McKesson Corporation
U.S. healthcare company
Follow McKesson Corporation on Notably News to receive short updates to your email — rarely!
| February 2025 | McKesson signed a definitive agreement to acquire 80% interest in PRISM Vision Holdings. |
| 2024 | McKesson reached $308.9 billion in annual revenue, becoming the ninth-largest company by revenue in the United States and the nation's largest healthcare company. |
| 2020 | Throughout the COVID-19 pandemic, McKesson served as the U.S. Government's centralized vaccine distributor, distributing hundreds of millions of COVID-19 vaccine doses and ancillary supply kits across the United States. |
| August 2020 | McKesson was selected by CDC and HHS as the centralized distributor for COVID-19 vaccine doses and supply kits under Operation Warp Speed. |
| February 2020 | McKesson divested its ownership in Change Healthcare and gave up its three seats on the company's board of directors. |
| April 2019 | Brian Tyler took over as CEO of McKesson Corporation. |
| April 1 2019 | McKesson completed its headquarters relocation to Irving, Texas. |
| November 2018 | McKesson announced plans to relocate its headquarters from San Francisco to Irving, Texas, effective April 1, 2019. |
| 2014 | McKesson acquired Celesio, becoming one of the world's largest healthcare companies with over $179 billion in annual revenue. |
| July 2012 | McKesson agreed to pay California and 28 other states $151 million to settle allegations of price inflation and Medicaid overbilling. |
| April 2012 | McKesson agreed to pay the United States $190 million to settle allegations of price inflation and Medicaid overbilling. |
| 2010 | McKesson acquired US Oncology, Inc. for $2.16 billion, integrating the company into McKesson Specialty Health business. |
This contents of the box above is based on material from the Wikipedia article McKesson Corporation, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.